Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

Healthcare is drawing fresh buying as money moves away from the market’s popular technology trade, and one messenger RNA (mRNA) name is pulling well ahead of the pack. Moderna (NASDAQ:MRNA | MRNA ...

Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a significant milestone for the company, which gets an opportunity to establish a ...

Moderna (NASDAQ:MRNA) shares climb on cancer vaccine optimism, index inclusion and a Health Canada flu vaccine review. See what's driving it.

Moderna (MRNA) stock surged 14% after reports of a new NIH cancer research initiative and encouraging trial data with Merck.

Add Yahoo as a preferred source to see more of our stories on Google. A Moderna logo is displayed on a building in Cambridge, Massachusetts, on Sept. 5, 2024. The Food and Drug Administration has ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In a first, the U.S. has approved an influenza vaccine that relies on mRNA technology—the same technology that underpinned the wildly successful Pfizer-BioNTech and Moderna COVID vaccines. The ...

The reason why is rather understandable: Moderna has been making some auspicious announcements. For starters, it has received regulatory approval for its updated COVID-19 vaccines. More intriguingly, ...

Few large biotech stocks have rewarded patience like Moderna (NASDAQ:MRNA | MRNA Price Prediction), and the size of that run ...

Shares of Nike Inc. NKE, Moderna Inc. MRNA and Walmart Inc. WMT climbed Thursday as money flowed out of tech and AI stocks ...